Article info
PDFScreening
Original research
Development and internal validation of a clinical risk score to predict incident renal and pulmonary tumours in people with tuberous sclerosis complex
- Correspondence to Dr Mark R Keezer, CRCHUM, Montreal, QC H2X 0C1, Canada; mark.keezer{at}umontreal.ca
Citation
Development and internal validation of a clinical risk score to predict incident renal and pulmonary tumours in people with tuberous sclerosis complex
Publication history
- Received October 29, 2023
- Accepted June 25, 2024
- First published July 8, 2024.
Article Versions
- Previous version (8 July 2024).
- Previous version (15 July 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.